Usted buscó: hypertrophy (Inglés - Maltés)

cartilage hypertrophy
ipertrofija tal-qarquċa

graft hypertrophy:
ipertrofija tat-trapjant:

injection site hypertrophy
ipertrofija fis-sit tal-injezzjoni

symptomatic graft hypertrophy
ipertrofija sintomatika tat-trapjant

tonsillar hypertrophy, snoring
ipertrofija tat- tunsilli, nħir

common: thymus hypertrophy
komuni: ipertrofija tat-timu

skin hypertrophy, rash, acne, alopecia
ipertrofija tal-ġilda, raxx, akne, alopeċja

breast tenderness hypertrophy breast
sensittività tas-sider ipertrofija fis-sider

gingival hypertrophy, dyspepsia, dry mouth
ipertrofija ġinġivali, dispepsja, ħalq xott

common: skin hypertrophy, abnormal hair texture
komuni: ipertrofija tal-ġilda, ix-xagħar jinħass abnormali

graft delamination graft complication graft hypertrophy
delaminazzjoni tat-trapjant komplikazzjoni tat-trapjant ipertrofija tat-trapjant

treatment of benign prostatic hypertrophy in male dogs.
trattament ta’ ipertrofija prostatika beninna fil-klieb ta’ sess maskili.

rare: tonsillar hypertrophy uncommon: adenoidal hypertrophy
rari: ipertrofija tat-tunsilli mhux komuni: ipertrofija tal-adenojdi

general disorders and administration injection site hypertrophy site conditions
disturbi ġenerali u kundizzjonijiet ta 'mnejn jingħata

symptomatic graft hypertrophy is acomplication that may occur with maci.
ipertrofija sintomatika tat-trapjant hija komplikazzjoni li jista’ jkun li sseħħ b’maci.

pharmacotherapeutic group: drugs used in benign prostatic hypertrophy.
grupp farmakoterapewtiku: drogi wżati f’ipertrofija prostatika beninna.

hypertrophy of the renal juxtaglomerular cells was also seen in both species.
fiż-żewġ speċi kienet osservata wkoll ipertrofija taċ-ċelluli jukstaglomerulari renali.

the hepatocellular centrilobular hypertrophy was consistent with rodent specific enzyme induction.
l-ipertrofija ċentrilobulari epatoċellulari kienet konsistenti ma’ l-induzzjoni ta’ l-enzimi speċifiċi għall-annimali gerriema.

apart from the hypertrophy of hepatocytes, no other histopathologic changes were observed.
minn barra l-ipertrofija tal-epatoċiti, ma deherux tibdiliet istopatoloġiċi oħra.

injection site hypertrophy (tissue at injection site increases in size) and bruising
ipertrofija fis-sit tal-injezzjoni (it-tessut fis-sit tal-injezzjoni jikber fid-daqs) u tbenġil